CPT 84080: Alkaline Phosphatase Isoenzyme Analysis

CPT code 84080 represents a laboratory assay that separates and quantifies alkaline phosphatase (ALP) isoenzymes. This test helps clinicians determine the tissue origin of abnormal ALP activity, which can be clinically important for differentiating liver, bone, and other disorders. Nationally, accurate reporting of this code supports clinical decision-making and appropriate laboratory reimbursement pathways for specialized enzymatic analysis.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of payer coverage patterns, common billing modifiers applicable to laboratory services, and typical sites of service for this assay. The publication also provides clinical context for when isoenzyme analysis is ordered and summarizes coding considerations relevant to laboratory billing teams.

The content highlights benchmarks and policy-relevant points that affect utilization and coding of specialized laboratory procedures. Data not available in the input is noted where applicable, and the focus remains on national implications for clinical laboratories, hospital labs, and billing departments responsible for correctly reporting CPT code 84080.

Billing Code Overview

CPT code 84080 describes a laboratory procedure that evaluates the levels of different forms of the enzyme alkaline phosphatase (ALP), known as ALP isoenzymes, in a patient specimen. The test separates and measures isoenzyme fractions to help identify the tissue source of elevated ALP and to aid clinical interpretation of liver, bone, or other disease processes.

Service type: Clinical laboratory test (isoenzyme analysis of alkaline phosphatase)
Typical site of service: Clinical laboratory or hospital laboratory setting

Clinical Context

A typical patient is an adult referred by a primary care clinician or hepatology service for evaluation of abnormal liver biochemical tests, specifically an isolated or predominant elevation in alkaline phosphatase (ALP). The patient presents with fatigue and mild right upper quadrant discomfort. Initial hepatic panel shows elevated total ALP; the clinician orders an alkaline phosphatase isoenzyme panel to distinguish hepatic from bone or placental sources. A phlebotomy visit is scheduled at an outpatient laboratory or hospital clinical laboratory; a venous blood specimen is collected, processed, and delivered to the clinical laboratory. A medical laboratory scientist or technologist performs electrophoresis or heat-inactivation and specific substrate assays to separate and quantify ALP isoenzymes. Results are reported to the ordering clinician and incorporated into the hepatology workup to guide further imaging (e.g., abdominal ultrasound, MRCP), bone evaluation, or medication review.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	When only the professional interpretation/reporting portion is billed separately from the technical work.
`TC`	Technical component

Taxonomy Code	Specialty	Notes
357S00000X	Clinical Laboratory	Laboratory directors and clinical laboratory scientists who oversee assay performance.
207L00000X	Pathology	Pathologists who provide laboratory oversight and result interpretation.
208000000X	Internal Medicine	Hospitalists and internists who order the test for liver/bone disease evaluation.
207RH0000X	Gastroenterology	Gastroenterologists/hepatologists who commonly evaluate elevated ALP and order isoenzyme testing.
2080P0207X	Family Medicine	Primary care clinicians who initiate testing during outpatient evaluation.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`K74.60`	Unspecified cirrhosis of liver	Chronic liver disease can alter hepatic ALP isoenzyme patterns and prompt isoenzyme testing.
`K83.1`	Obstruction of bile duct	Cholestatic processes raise hepatic ALP and motivate isoenzyme differentiation.
`M81.0`	Age-related osteoporosis without current pathological fracture	Bone disease can elevate bone ALP isoenzyme; testing differentiates bone versus liver source.
`C22.0`	Liver cell carcinoma	Hepatic neoplasms may change isoenzyme expression; isoenzyme testing can be part of tumor-related evaluation.
`O09.9`	Pregnancy, unspecified	Placental ALP isoenzyme rises in pregnancy; isoenzyme testing distinguishes placental source from liver/bone.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80053`	Comprehensive metabolic panel	Often performed alongside ALP isoenzyme testing as part of broader liver function assessment.
`82040`	Albumin; any method	Frequently ordered with liver panels for synthetic function assessment.
`84300`	Phosphatase, alkaline; total	Total alkaline phosphatase measurement typically precedes isoenzyme fractionation to confirm elevation.
`76700`	Ultrasound, abdominal, real time with image documentation; limited	Imaging commonly follows abnormal ALP isoenzymes to evaluate biliary obstruction or hepatic lesions.
`87491`	Infectious agent detection by nucleic acid; direct probe technique	Used when infectious causes of cholestasis (e.g., viral hepatitis) are investigated (example of ancillary testing).

OpenPayer

Summary & Overview